Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment – News-Medical.net
News-Medical.net |
Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment
News-Medical.net Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment. The findings … Stem cell biomarker predicts leukemia patients’ response to chemoFierceBiotech Signature of 17 Genes Could Predict Prognosis in AML PatientsGenomeWeb Cancer vaccine prolongs remission in leukemia patients in trialKSAT San Antonio |
FierceBiotech |
Stem cell biomarker predicts leukemia patients’ response to chemo
FierceBiotech The new biomarker, dubbed LSC17, is derived from leukemia stem cells. These cells promote cancer development and can elude chemotherapy, lying dormant and causing relapse even in patients who are in remission after therapy. LSC17 could become a … New stem cell-based gene test predicts patient risk in acute myeloid leukemiaU of T Engineering News Signature of 17 Genes Could Predict Prognosis in AML PatientsGenomeWeb Cancer vaccine prolongs remission in leukemia patients in trialKSAT San Antonio |
VICE News |
Selling miracles Cerebral palsy patients are spending thousands on unproven stem cell therapies
VICE News “If you can’t see the difference between a child in a wheelchair and one standing up walking, there’s something wrong with you,” stem cell therapist Dr. David Steenblock told VICE News correspondent Ravi Somaiya in San Clemente, California. “If it’s a … |
FierceBiotech |
Voyager Gene Therapy Shows Early, Promising Motor Function Improvements for Parkinson’s Patients
TheStreet.com A Voyager Therapeutics (VYGR) gene therapy delivered surgically, once, to the brain of a small number of patients with advanced Parkinson’s disease is demonstrating early signs that it can improve motor function, according to interim results from a … Parkinson’s gene therapy data sparks Voyager stock jumpFierceBiotech Cambridge gene therapy firm Voyager gets positive results on Parkinson’s treatmentBoston Business Journal Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small StudyXconomy Business Insider –The Boston Globe all 30 news articles » |
Capitol Weekly |
Stem cell agency okays $15 million for new research
Capitol Weekly After a hiccup last month, the California stem cell agency this week coughed up $15 million for a quartet of researchers looking into Alzheimer’s disease, cartilage repair, arthritis and sickle cell disease, but not before lopping off a big chunk of … |
Medical Xpress |
Stem cell-based test predicts leukemia patients’ response to therapy to help tailor treatment
Science Daily The new biomarker is named the LSC17 score as it comes from the leukemia stem cells that drive disease and relapse. These dormant stem cells have properties that allow them to resist standard chemotherapy, which is designed to defeat rapidly dividing … Signature of 17 Genes Could Predict Prognosis in AML PatientsGenomeWeb |
CNN |
Experimental SkinGun heals burns using stem cells
CNN The product, from New York biotech firm RenovaCare, is rooted in cutting-edge stem cell research. The CellMist System harvests a patient’s stem cells from a small area of unwounded skin (usually one square inch) and suspends them in a water-based … |
|
Experimental SkinGun heals burns using stem cells
Gant Daily The product, from New York biotech firm RenovaCare, is rooted in cutting-edge stem cell research. The CellMist System harvests a patient’s stem cells from a small area of unwounded skin (usually one square inch) and suspends them in a water-based … |